{"transactions":[{"id":774428,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:37:06.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":4137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7237,"source":{"system":"sec-edgar","filing":"0002064832-26-000210","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000206483226000210/form4.xml","form_type":"4"}},{"id":1144912,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:41:41.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":4543,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4543,"derivative":{"exercise_price":78.81,"exercise_date":"2026-05-14","expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":4543},"source":{"system":"sec-edgar","filing":"0001062993-25-009698","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009698/form4.xml","form_type":"4"}},{"id":1144911,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:41:41.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":2537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3100,"source":{"system":"sec-edgar","filing":"0001062993-25-009698","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325009698/form4.xml","form_type":"4"}},{"id":1271207,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-12T22:15:58.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":1015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 originally filed on February 11, 2025, inadvertently reported 1,017 options granted on February 7, 2025, due to an administrative error. The correct number of options granted on February 7, 2025, is 1,015 and is being reported in this amendment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Form 4 originally filed on February 11, 2025, inadvertently reported 1,017 options granted on February 7, 2025, due to an administrative error. The correct number of options granted on February 7, 2025, is 1,015 and is being reported in this amendment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 originally filed on February 11, 2025, inadvertently reported 1,017 options granted on February 7, 2025, due to an administrative error. The correct number of options granted on February 7, 2025, is 1,015 and is being reported in this amendment."}],"balance_after":1015,"derivative":{"exercise_price":88.71,"exercise_date":"2026-02-07","expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":1015},"source":{"system":"sec-edgar","filing":"0001062993-25-002208","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325002208/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-11"}},{"id":1273535,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-11T21:31:12.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":1017,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1017,"derivative":{"exercise_price":88.71,"exercise_date":"2026-02-07","expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":1017},"source":{"system":"sec-edgar","filing":"0001062993-25-002103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325002103/form4.xml","form_type":"4"}},{"id":1273534,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T21:31:12.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":563,"source":{"system":"sec-edgar","filing":"0001062993-25-002103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1521036/000106299325002103/form4.xml","form_type":"4"}},{"id":1759028,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-17T21:52:27.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023."}],"balance_after":16667,"derivative":{"exercise_price":44.31,"expiration_date":"2033-10-13","underlying":"Common Shares","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000950170-23-053819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023053819/ownership.xml","form_type":"4"}},{"id":1878155,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-25T21:35:47.000Z","date":"2023-05-23","kind":"exercise","planned":false,"acquired":true,"shares":6938,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026."}],"balance_after":20812,"derivative":{"underlying":"Common Shares","underlying_shares":6938},"source":{"system":"sec-edgar","filing":"0001209191-23-032250","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123032250/doc4.xml","form_type":"4"}},{"id":1878154,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2023-05-25T21:35:47.000Z","date":"2023-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2527,"price":65.91,"value":166554.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 23, 2022, the reporting person was granted 27,750 restricted stock units. On May 23, 2023, 6,938 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":4411,"source":{"system":"sec-edgar","filing":"0001209191-23-032250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123032250/doc4.xml","form_type":"4"}},{"id":1878153,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2023-05-25T21:35:47.000Z","date":"2023-05-23","kind":"exercise","planned":false,"acquired":true,"shares":6938,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on May 23, 2023, (ii) one quarter of the shares shall vest on May 23, 2024, (iii) one quarter of the shares shall vest on May 23, 2025, and (iv) one quarter of the shares shall vest on May 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":6938,"source":{"system":"sec-edgar","filing":"0001209191-23-032250","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123032250/doc4.xml","form_type":"4"}},{"id":1954211,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:44:07.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":22000,"derivative":{"underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-23-018561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018561/doc4.xml","form_type":"4"}},{"id":1954210,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-14T21:44:07.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":44620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 10, 2023 with respect to 44,620 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023."}],"balance_after":44620,"derivative":{"exercise_price":43.22,"expiration_date":"2033-03-10","underlying":"Common Shares","underlying_shares":44620},"source":{"system":"sec-edgar","filing":"0001209191-23-018561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018561/doc4.xml","form_type":"4"}},{"id":2138322,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-12T21:41:39.000Z","date":"2022-10-07","kind":"grant","acquired":true,"shares":9380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 7, 2022 with respect to 9,380 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022."}],"balance_after":9380,"derivative":{"exercise_price":61.65,"expiration_date":"2032-10-07","underlying":"Common Shares","underlying_shares":9380},"source":{"system":"sec-edgar","filing":"0001209191-22-053496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122053496/doc4.xml","form_type":"4"}},{"id":2258312,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-24T21:55:33.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 23, 2022 with respect to 90,000 Common Shares, with 25% of the shares vesting on May 23, 2023 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":90000,"derivative":{"exercise_price":54.71,"expiration_date":"2032-05-23","underlying":"Common Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-031705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122031705/doc4.xml","form_type":"4"}},{"id":2258311,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":46341,"kind":"person","name":"Morrow Phuong Khanh","position":1,"cik":"0001928989","reported_name":"Morrow Phuong Khanh","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-24T21:55:33.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":27750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 23, 2022 with respect to 27,750 Common Shares, with (i) one quarter of the shares vesting on May 23, 2023, (ii) one quarter of the shares vesting on May 23, 2024, (iii) one quarter of the shares vesting on May 23, 2025, and (iv) one quarter of the shares vesting on May 23, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 23, 2022 with respect to 27,750 Common Shares, with (i) one quarter of the shares vesting on May 23, 2023, (ii) one quarter of the shares vesting on May 23, 2024, (iii) one quarter of the shares vesting on May 23, 2025, and (iv) one quarter of the shares vesting on May 23, 2026."}],"balance_after":27750,"derivative":{"underlying":"Common Shares","underlying_shares":27750},"source":{"system":"sec-edgar","filing":"0001209191-22-031705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122031705/doc4.xml","form_type":"4"}}]}